1-40257946-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000567508.3(ZMPSTE24-DT):n.49C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0984 in 350,266 control chromosomes in the GnomAD database, including 1,928 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 902 hom., cov: 32)
Exomes 𝑓: 0.094 ( 1026 hom. )
Consequence
ZMPSTE24-DT
ENST00000567508.3 non_coding_transcript_exon
ENST00000567508.3 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.172
Publications
11 publications found
Genes affected
ZMPSTE24-DT (HGNC:55402): (ZMPSTE24 divergent transcript)
ZMPSTE24 (HGNC:12877): (zinc metallopeptidase STE24) This gene encodes a member of the peptidase M48A family. The encoded protein is a zinc metalloproteinase involved in the two step post-translational proteolytic cleavage of carboxy terminal residues of farnesylated prelamin A to form mature lamin A. Mutations in this gene have been associated with mandibuloacral dysplasia and restrictive dermopathy. [provided by RefSeq, Jul 2008]
ZMPSTE24 Gene-Disease associations (from GenCC):
- lethal restrictive dermopathyInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet
- mandibuloacral dysplasia with type B lipodystrophyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- restrictive dermopathy 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Hutchinson-Gilford progeria syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 1-40257946-G-A is Benign according to our data. Variant chr1-40257946-G-A is described in ClinVar as [Benign]. Clinvar id is 140505.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.145 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZMPSTE24-DT | ENST00000567508.3 | n.49C>T | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
ZMPSTE24 | ENST00000674703.1 | n.-326G>A | upstream_gene_variant | ENSP00000501674.1 | ||||||
ZMPSTE24 | ENST00000675937.1 | n.-326G>A | upstream_gene_variant | ENSP00000502683.1 |
Frequencies
GnomAD3 genomes AF: 0.103 AC: 15727AN: 152126Hom.: 900 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
15727
AN:
152126
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0944 AC: 18700AN: 198022Hom.: 1026 Cov.: 3 AF XY: 0.0975 AC XY: 10162AN XY: 104234 show subpopulations
GnomAD4 exome
AF:
AC:
18700
AN:
198022
Hom.:
Cov.:
3
AF XY:
AC XY:
10162
AN XY:
104234
show subpopulations
African (AFR)
AF:
AC:
656
AN:
6652
American (AMR)
AF:
AC:
1065
AN:
8722
Ashkenazi Jewish (ASJ)
AF:
AC:
330
AN:
5900
East Asian (EAS)
AF:
AC:
1386
AN:
10902
South Asian (SAS)
AF:
AC:
3758
AN:
27110
European-Finnish (FIN)
AF:
AC:
888
AN:
10444
Middle Eastern (MID)
AF:
AC:
55
AN:
820
European-Non Finnish (NFE)
AF:
AC:
9555
AN:
116212
Other (OTH)
AF:
AC:
1007
AN:
11260
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
819
1638
2457
3276
4095
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.103 AC: 15757AN: 152244Hom.: 902 Cov.: 32 AF XY: 0.105 AC XY: 7797AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
15757
AN:
152244
Hom.:
Cov.:
32
AF XY:
AC XY:
7797
AN XY:
74440
show subpopulations
African (AFR)
AF:
AC:
4616
AN:
41550
American (AMR)
AF:
AC:
2074
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
195
AN:
3470
East Asian (EAS)
AF:
AC:
792
AN:
5176
South Asian (SAS)
AF:
AC:
744
AN:
4824
European-Finnish (FIN)
AF:
AC:
984
AN:
10600
Middle Eastern (MID)
AF:
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6077
AN:
68012
Other (OTH)
AF:
AC:
208
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
721
1442
2162
2883
3604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
480
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
-
ZMPSTE24 homepage - Leiden Muscular Dystrophy pages
Significance:not provided
Review Status:no classification provided
Collection Method:literature only
- -
Sep 04, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.